-
Product Insights
Chronic Urticaria Or Hives – Drugs In Development, 2023
Global Markets Direct’s, ‘Chronic Urticaria Or Hives - Drugs In Development, 2023’, provides an overview of the Chronic Urticaria Or Hives pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Urticaria Or Hives, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Inhalers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Inhalers Pipeline Market Report Overview Inhalers deliver medication to the lungs. The inhalers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segment ·       Dry Powder Inhaler Devices Key Territories ·       The US ·       Europe ·       Australia...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AZD-0171 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AZD-0171 in Metastatic Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AZD-0171 in Metastatic Pancreatic Cancer Drug Details: MSC-1 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – WP-1066 in Recurrent Medulloblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - WP-1066 in Recurrent Medulloblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.WP-1066 in Recurrent MedulloblastomaDrug Details:WP-1066 is under development for the treatment of metastatic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – WP-1066 in Refractory Medulloblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - WP-1066 in Refractory Medulloblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.WP-1066 in Refractory MedulloblastomaDrug Details:WP-1066 is under development for the treatment of metastatic...
-
Product Insights
Connected patient in healthcare: Continuous vitals monitoring
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the healthcare industry’s Continuous vitals monitoring within Connected patient innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep...
-
Company Profile
Ajinomoto Co Inc – Company Profile
Ajinomoto Co Inc (Ajinomoto) is a diversified company, majorly focuses on foods, bioscience, fine chemicals, and pharmaceuticals and health products. It is involved in research, development and production of sauce, seasonings, and quick nourishment products including cup soup and coffee. It also provides office supplies, coffee vending machines, bakery products, frozen and processed foods, edible oils, amino acids, and animal nutrition products. In addition, Ajinomoto undertakes contract manufacturing and developing pharmaceutical intermediates and active pharmaceutical ingredients. Its portfolio also comprises...
Add to Basket -
Product Insights
Renal Dialysis Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Renal Dialysis Equipment Pipeline Market Report Overview Renal dialysis equipment is intended to provide an artificial replacement for lost kidney function due to renal failure. Dialysis machines, dialysis accessories, vascular access devices for hemodialysis, and stone management disposables are covered in this category. The renal dialysis equipment pipeline market research report provides comprehensive information about the renal dialysis equipment pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Company Profile
Therapeutic Solutions International Inc – Company Profile
Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that developed immune modulation for the treatment of several specific diseases. The company product pipeline includes ARDScells Phase 3, JadiCell ARDS Phase 3, CTEcells Phase 1/2, StemVacs-A Phase 1, StemVacs-V Phase 1/2, ALScells, StemVacs-E, StemVacs-P, StemVacs-L, JadiCell_DC_Exosomes, JadiCell Lithium, JadiCell Schizophrenia, LymphoBoost, JadiCell Neurogenesis, NarcoStem. The therapeutic Solutions pipeline also includes NeuroLeukin, CampbellCell, siRNA ARDS, RNA/CTE and VSX-001. Therapeutic Solutions is headquartered in Oceanside, California‎, the US.
Add to Basket -
Company Profile
Immunic Inc – Company Profile
Immunic Inc (Immunic Therapeutics) is a biopharmaceutical company that discover, develops and commercializes oral immunology therapies to treat chronic inflammatory and autoimmune diseases. The company’s pipeline products include IMU-838, a selective immune modulator for the treatment of relapsing-remitting multiple sclerosis (RRMS), inflammatory bowel disease (IBD), other chronic inflammatory and autoimmune diseases; IMU-856, an orally small molecule modulator to treat intestinal barrier function; and IMU-935, an immunology therapy targeting RORγt and Th17. It also evaluating therapies targeting primary sclerosing cholangitis (PSC)...
Add to Basket